Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus

L. D. Lilien, G. Srinivasan, T. F. Yeh, R. S. Pildes

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.

Original languageEnglish
Pages (from-to)73-77
Number of pages5
JournalPediatric Pharmacology
Volume5
Issue number1
Publication statusPublished - Jan 1 1985
Externally publishedYes

Fingerprint

Patent Ductus Arteriosus
Premature Infants
Indomethacin
Glucose
Insulin
Therapeutics
Carbohydrate Metabolism
Intravenous Infusions
Birth Weight
Intravenous Administration
Gestational Age
Prostaglandins

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus. / Lilien, L. D.; Srinivasan, G.; Yeh, T. F.; Pildes, R. S.

In: Pediatric Pharmacology, Vol. 5, No. 1, 01.01.1985, p. 73-77.

Research output: Contribution to journalArticle

@article{81c567ea0486481fbc195e32d2f683d9,
title = "Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus",
abstract = "The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.",
author = "Lilien, {L. D.} and G. Srinivasan and Yeh, {T. F.} and Pildes, {R. S.}",
year = "1985",
month = "1",
day = "1",
language = "English",
volume = "5",
pages = "73--77",
journal = "Pediatric Pharmacology",
issn = "0270-322X",
number = "1",

}

TY - JOUR

T1 - Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus

AU - Lilien, L. D.

AU - Srinivasan, G.

AU - Yeh, T. F.

AU - Pildes, R. S.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.

AB - The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.

UR - http://www.scopus.com/inward/record.url?scp=0021944080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021944080&partnerID=8YFLogxK

M3 - Article

C2 - 3887313

AN - SCOPUS:0021944080

VL - 5

SP - 73

EP - 77

JO - Pediatric Pharmacology

JF - Pediatric Pharmacology

SN - 0270-322X

IS - 1

ER -